Drug Pipeline

Nusinersen Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
2
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04729907 A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given… Muscular Atrophy, Spinal Active, Not Recruiting
NCT05067790 A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given as… Spinal Muscular Atrophy Active, Not Recruiting
Phase 2
NCT07047144 A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and… Spinal Muscular Atrophy Recruiting
Phase 1
NCT06555419 A Study to Find Out How Nusinersen is Processed in the Body When Given Through the… Muscular Atrophy, Spinal Recruiting
Sponsors Running Nusinersen Trials
Biogen (3) Scholar Rock, Inc. (1)
Disease Areas
Spinal Muscular Atrophy (2)
Get alerts when Nusinersen trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free